Paul Anthony Brennan, Former at InMed Pharmaceuticals, holds 1.10M shares in InMed Pharmaceuticals (Ticker: INM), holds 619.35K shares in NervGen Pharma (Ticker: NGENF), holds 7.00K shares in Arbutus Biopharma (Ticker: ABUS). Most recently, Paul Anthony Brennan ― shares of InMed Pharmaceuticals on ― for an estimated value of ―.